Uemasu J, Fujiwara M, Munemura C, Tokumoto A, Kawasaki H
Second Department of Internal Medicine, Tottori University School of Medicine, Yonago, Japan.
Clin Nephrol. 1993 Mar;39(3):140-4.
To reduce renal cyst size in autosomal dominant polycystic kidney disease (ADPKD), minocycline hydrochloride solution was instilled into the enlarged cysts in three ADPKD patients. In one patient with reduced renal function, such sclerotherapy apparently diminished cyst size, but without apparent improving effect on renal function at 7 months of follow-up. The second patient, who needed the replacement therapy on admission, had been free from hemodialysis over 4 months after the therapy. Persistent flank pain disappeared in both patients. In the third patient with normal renal function, sclerotherapy was done to get a better control of hypertension. Initially blood pressure decreased, but it returned up to the pre-therapy level irrespective of definite reduction of the enlarged cysts at 8 months of follow-up. The therapy with minocycline hydrochloride did not appear harmful, and may be helpful in the management of ADPKD.
为了减小常染色体显性多囊肾病(ADPKD)患者的肾囊肿大小,将盐酸米诺环素溶液注入3例ADPKD患者增大的囊肿中。在1例肾功能减退的患者中,这种硬化疗法明显减小了囊肿大小,但在随访7个月时对肾功能没有明显改善作用。第2例患者入院时需要替代治疗,治疗后4个多月未进行血液透析。两名患者的持续性胁腹疼痛均消失。在第3例肾功能正常的患者中,进行硬化疗法以更好地控制高血压。最初血压下降,但在随访8个月时,尽管增大的囊肿明显缩小,血压仍回升至治疗前水平。盐酸米诺环素治疗似乎没有危害,可能有助于ADPKD的管理。